Femasys Inc.

Femasys Inc. is a biomedical company specializing in women's healthcare solutions. The company's primary focus is on developing and commercializing a range of products for permanent birth control, artificial insemination, endocervical curettage, and uterine cancer detection testing. Their products, including FemBloc, FemChec, FemaSeed, FemCerv, and FemEMB, are targeted at obstetrics-gynecological physicians, reproductive endocrinologists, and women's healthcare provider organizations. Femasys also offers non-surgical product technologies to support their core offerings, generating revenue from sales in the United States, Europe, Canada, Japan, and other international markets.

Products

• Permanent birth control solutions

• Artificial insemination solution

• Biopsy device for endocervical curettage

• Product candidate for endometrial sampling